Selventa
The company is developing a test to predict RA patients' response to various drugs beginning with anti-TNF therapy, which it highlighted in a recent publication.
IP Update: Intelligent Biosystems, MIT, Metabolon, among Recent Bioinformatics Patent Winners
Premium
Title: Methods and compositions for base calling nucleic acids
US Patent Number: 8,612,161
YarcData, a spinoff from supercomputing firm Cray, and Selventa, a bioinformatics firm that serves the pharmaceutical industry, have signed an agreement that allows the latter to run its data analysis engine on Urika, YarcData's graph analytics appliance (
This week, the Linux Foundation, a non-profit consortium that supports the Linux operating system, announced that the publicly available version of Selventa's Biological Expression Language, OpenBEL, is now one of its collaborative projects.
MDx/CDx Focus: Abbott, Epizyme Advance CDx for Novel Leukemia Drug; Segeene, Selventa Develop MDx
Premium
Epizyme, Abbott Developing CDx for Mixed Lineage Leukemia Drug
Epizyme and Abbott announced they are working together to develop a molecular diagnostic to accompany its investigational treatment for mixed lineage leukemia, EPZ-5676.
Jan 25, 2013
Apr 20, 2012
Feb 27, 2012
Selventa, Janssen Partner on Immunological Diseases
Jan 20, 2012
Dec 9, 2011
Dec 1, 2011
Selventa Raises $5M
Sep 16, 2011
Aug 19, 2011
People In The News: Aug 19, 2011
Aug 19, 2011
Aug 19, 2011
Movers & Shakers: Aug 19, 2011
Premium
Jul 1, 2011
Mar 25, 2011
Dec 10, 2010